2025年雷洛昔芬最新价格是多少钱一盒？

Raloxifene is a selective estrogen receptor modulator that is widely used for the treatment and prevention of osteoporosis in postmenopausal women and can reduce the incidence of invasive breast cancer in high-risk women. In 2025, the price of raloxifene will vary depending on the manufacturer and specifications. The product prices of Nippon Medical Industries Co., Ltd. and Eli Lilly and Company of the United States will be around US$42 and US$70 respectively.

What is the latest price of a box of raloxifene in 2025?

The price is affected by factors such as manufacturer, specification and region. The market price in 2025 shows that there are certain differences in the prices of different versions.

Nikko Co., Ltd. version

The specification of raloxifene produced by Nippon Koko Co., Ltd. is 60mg*100 tablets/box, and the price in 2025 will be approximately US$42 per box. This version is the choice of many patients because of its relatively low price.

American Eli Lilly and Company version

The trade name of raloxifene produced by American Eli Lilly and Company is Evista, with the same specifications of 60mg*100 tablets/box, and the price in 2025 is about US$70 per box. As a manufacturer of original drugs, Eli Lilly's products are more expensive, but their quality and efficacy are guaranteed.

Factors affecting price

The price difference of raloxifene is mainly due to production costs, brand premiums and regional medical insurance policies. The emergence of generic drugs has further reduced market prices and provided patients with more choices.

Understanding the price information of raloxifene can help patients choose the appropriate version of the drug based on their own economic conditions, and can also better plan the cost of treatment.

Global marketing status of raloxifene

Since its first approval in 1997, raloxifene has been launched in many countries and regions around the world and has become an important drug in the prevention and treatment of osteoporosis and breast cancer.

U.S. market

Raloxifene was developed by Eli Lilly and Company of the United States and was approved by the FDA for marketing in 1997 under the trade name Evista. The U.S. market is dominated by original drugs, which are more expensive but cover a wide range of indications.

Chinese market

Raloxifene has been launched in China and has been included in the medical insurance catalog. There are both original drugs and generic drugs on the market, providing patients with more choices, and the coverage of medical insurance policies further reduces the financial burden on patients.

Other regions

Raloxifene has also been approved for marketing in Europe, Japan and other regions. The indications and medication specifications are basically the same as those in the U.S. market. Prices and medical insurance policies in different regions are slightly different.

The global launch of raloxifene reflects its important position in the fields of osteoporosis and breast cancer prevention and treatment, and also provides treatment options for patients in different regions.

Preparation for taking raloxifene

Patients need to understand its usage, dosage, adverse reactions and precautions before taking the medicine.

Usage and Dosage

The recommended dose of raloxifene is 60 mg orally, once a day, and the dosage time is not affected by meals. At the same time, patients need to pay attention to supplementing calcium and vitamin D. The daily intake of elemental calcium should reach 1500mg, and the recommended daily intake of vitamin D is 400-800IU.

Adverse reactions

Raloxifene may cause common adverse reactions such as hot flashes, leg cramps and peripheral edema. Serious adverse reactions include an increased risk of venous thromboembolism and stroke death, and patients need to pay close attention.

Usage for special groups

Raloxifene is contraindicated in pregnant women, lactating women, women of reproductive potential and children. The elderly and those with mild to moderate renal impairment do not need to adjust the dose, but they need to use the drug with caution.

Understanding the preparation of raloxifene medication can help patients use the drug safely and effectively, avoid potential risks, and maximize the therapeutic effect.